Generation and analysis of serine protease inhibitor Kazal type 3-Cre driver mice

Experimental Animals

Volumn 63, Issue 1, 2014, Pages 45-53

  Sakata, Kazuya ^a   Ohmuraya, Masaki ^a   Araki, Kimi ^a   Suzuki, Chigure ^b   Ida, Satoshi ^a   Hashimoto, Daisuke ^a   Wang, Jung ^c   Uchiyama, Yasuo ^b   Baba, Hideo ^a   Yamamura, Ken Ichi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

SPINK1; Spink3; Spink3cre mice; Spink3lacZ mice

Indexed keywords

BETA GALACTOSIDASE; CRE RECOMBINASE; EPIDERMAL GROWTH FACTOR; MESSENGER RNA; SERINE PROTEASE INHIBITOR KAZAL TYPE3; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ADULT; ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BETA GALACTOSIDASE ACTIVITY; CONTROLLED STUDY; EMBRYONIC STEM CELL; ENZYME ACTIVITY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE TARGETING; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; WESTERN BLOTTING;

ACINAR CELLS; ANIMALS; BETA-GALACTOSIDASE; CELL LINE; EPITHELIAL CELLS; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GLYCOPROTEINS; INTEGRASES; KIDNEY; LAC OPERON; LUNG; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PANCREAS; PROMOTER REGIONS, GENETIC; PROSTATIC SECRETORY PROTEINS;

EID: 84896737227     PISSN: 13411357     EISSN: None     Source Type: Journal    
DOI: 10.1538/expanim.63.45     Document Type: Article

References (19)

1. Araki, K., Araki, M., and Yamamura, K. 2002. Site-directed integration of the cre gene mediated by Cre recombinase using a combination of mutant lox sites. Nucleic. Acids Res. 30: e103. [Medline] [CrossRef]
2. Araki, K., Araki, M., and Yamamura, K. 2006. Negative selection with the Diphtheria toxin A fragment gene improves frequency of Cre-mediated cassette exchange in ES cells. J. Biochem. 140: 793-798. [Medline] [CrossRef]
3. Araki, K., Okada, Y., Araki, M., and Yamamura, K. 2010. Comparative analysis of right element mutant lox sites on recombination efficiency in embryonic stem cells. BMC Biotechnol. 10: 29. [Medline] [CrossRef]
4. Freeman, T.C., Playford, R.J., Quinn, C., Beardshall, K., Poulter, L., Young, J., and Calam, J. 1990. Pancreatic secretory trypsin inhibitor in gastrointestinal mucosa and gastric juice. Gut 31: 1318-1323. [Medline] [CrossRef]
5. Kazal, L.A., Spicer, D.S., and Brahinsky, R.A. 1948. Isolation of a crystalline trypsin inhibitor-anticoagulant protein from pancreas. J. Am. Chem. Soc. 70: 3034-3040. [Medline] [CrossRef]
6. Kobayashi, K., Horiuchi, M., and Saheki, T. 1997. Pancreatic secretory trypsin inhibitor as a diagnostic marker for adult-onset type II citrullinemia. Hepatology 25: 1160-1165. [Medline] [CrossRef]
7. Marchbank, T., Chinery, R., Hanby, A.M., Poulsom, R., Elia, G., and Playford, R.J. 1996. Distribution and expression of pancreatic secretory trypsin inhibitor and its possible role in epithelial restitution. Am. J. Pathol. 148: 715-722. [Medline]
8. Niwa, H., Yamamura, K., and Miyazaki, J. 1991. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108: 193-199. [Medline] [CrossRef]
9. Ohmachi, Y., Murata, A., Matsuura, N., Yasuda, T., Yasuda, T., Monden, M., Mori, T., Ogawa, M., and Matsubara, K. 1993. Specific expression of the pancreatic-secretory-trypsin-inhibitor (PSTI) gene in hepatocellular carcinoma. Int. J. Cancer 55: 728-734. [Medline] [CrossRef]
10. Ohmuraya, M., Hirota, M., Araki, M., Mizushima, N., Matsui, M., Mizumoto, T., Haruna, K., Kume, S., Takeya, M., Ogawa, M., Araki, K., and Yamamura, K. 2005. Autophagic cell death of pancreatic acinar cells in serine protease inhibitor Kazal type 3-deficient mice. Gastroenterology 129: 696-705. [Medline]
11. Ohmuraya, M., Sugano, A., Hirota, M., Takaoka, Y., and Yamamura, K. 2012. Role of Intrapancreatic SPINK1/Spink3 Expression in the Development of Pancreatitis. Front. Physiol. 3: 126. [Medline] [CrossRef]
12. Ozaki, N., Ohmuraya, M., Hirota, M., Ida, S., Wang, J., Takamori, H., Higashiyama, S., Baba, H., and Yamamura, K. 2009. Serine protease inhibitor Kazal type 1 promotes proliferation of pancreatic cancer cells through the epidermal growth factor receptor. Mol. Cancer Res. 7: 1572-1581. [Medline] [CrossRef]
13. Playford, R.J., Batten, J.J., Freeman, T.C., Beardshall, K., Vesey, D.A., Fenn, G.C., Baron, J.H., and Calam, J. 1991. Gastric output of pancreatic secretory trypsin inhibitor is increased by misoprostol. Gut 32: 1396-1400. [Medline] [CrossRef]
14. Scheving, L.A. 1983. Primary amino acid sequence similarity between human epidermal growth factor-urogastrone, human pancreatic secretory trypsin inhibitor, and members of porcine secretin family. Arch. Biochem. Biophys. 226: 411-413. [Medline] [CrossRef]
15. Soriano, P. 1999. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21: 70-71. [Medline] [CrossRef]
16. Stenman, U.H., Huhtala, M.L., Koistinen, R., and Seppala, M. 1982. Immunochemical demonstration of an ovarian cancer-associated urinary peptide. Int. J. Cancer 30: 53-57. [Medline] [CrossRef]
17. Wang, J., Ohmuraya, M., Hirota, M., Baba, H., Zhao, G., Takeya, M., Araki, K., and Yamamura, K. 2008. Expression pattern of serine protease inhibitor kazal type 3 (Spink3) during mouse embryonic development. Histochem. Cell Biol. 130: 387-397. [Medline] [CrossRef]
18. Witt, H., Apte, M.V., Keim, V., and Wilson, J.S. 2007. Chronic pancreatitis: challenges and advances in pathogenesis, genetics, diagnosis, and therapy. Gastroenterology 132: 1557-1573. [Medline] [CrossRef]
19. Yasuda, T., Ogawa, M., Murata, A., Ohmachi, Y., Yasuda, T., Mori, T., and Matsubara, K. 1993. Identification of the IL-6-responsive element in an acute-phase-responsive human pancreatic secretory trypsin inhibitor-encoding gene. Gene 131: 275-280. [Medline] [CrossRef]